Cigarette Smoking and Risk of Non-Hodgkin's Lymphoma—A Population-Based Case-Control Study
- Claudia Schöllkopf1,
- Karin Ekström Smedby2,
- Henrik Hjalgrim1,
- Klaus Rostgaard1,
- Ole Gadeberg5,
- Göran Roos6,
- Anna Porwit-MacDonald4,
- Bengt Glimelius3,7,
- Hans-Olov Adami2 and
- Mads Melbye1
- 1Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark; 2Department of Medical Epidemiology and Biostatistics and 3Department of Pathology and Oncology, Karolinska Institutet; 4Department of Pathology, Karolinska University Hospital, Stockholm, Sweden; 5Department of Medicine, Vejle Hospital, Vejle, Denmark; 6Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden; and 7Department of Oncology, Radiology, and Clinical Immunology, Uppsala University, Uppsala, Sweden
- Requests for reprints:
Claudia Schöllkopf, Department of Epidemiology Research, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen, Denmark; Phone: 45-3268-3222; Fax: 45-3268-3165. E-mail: CKO{at}SSI.dk
Abstract
Background: Epidemiologic evidence of an association between tobacco smoking and non-Hodgkin's lymphoma has been conflicting. This may reflect that non-Hodgkin's lymphoma comprises several distinct disease entities with different etiologies, as some studies have indicated an association between smoking and follicular lymphoma.
Objective: To investigate the association between cigarette smoking and non-Hodgkin's lymphoma risk, overall and by subtype.
Methods: As part of a nationwide Danish-Swedish population-based case-control study, we interviewed 3,055 incident non-Hodgkin's lymphoma patients and 3,187 population controls. All lymphomas were uniformly classified according to the WHO classification. We used unconditional logistic regression to estimate adjusted odds ratios (OR) and 95% confidence intervals (95% CI) for the association between cigarette smoking and risk of non-Hodgkin's lymphoma.
Results: Cigarette smoking was not associated with the risk of non-Hodgkin's lymphoma overall (OR, 0.97; 95% CI, 0.87-1.08) nor with the major subgroups such as diffuse large B-cell lymphoma (OR, 0.94; 95% CI, 0.79-1.10), chronic lymphocytic leukemia (OR, 0.86; 95% CI, 0.72-1.02), or follicular lymphoma (OR, 1.03; 95% CI, 0.85-1.24). Female smokers were at a marginally increased risk of follicular lymphoma (OR, 1.41; 95% CI, 1.04-1.92). Men who had ever smoked had a significantly increased risk of T-cell lymphoma (OR, 1.67; 95% CI, 1.11-2.51). No dose-response association with cigarette smoking could be established for any lymphoma subgroup.
Conclusion: We found little evidence of an association between cigarette smoking and non-Hodgkin's lymphoma risk overall. Although increased risks of follicular lymphoma in female smokers and of T-cell lymphoma in male smokers were suggested, no dose-response relationship was observed, leaving limited support for causality.
Footnotes
-
Grant support: The Danish-Swedish study of the epidemiology of malignant lymphomas has been funded by grants from the NIH (#5 R01 CA69269-02), the Swedish Cancer Society (#02 6661), and Plan Denmark.
-
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
- Accepted April 29, 2005.
- Received February 17, 2005.
- Revision received April 13, 2005.










